Works matching IS 00071048 AND DT 2009 AND VI 144 AND IP 1


Results: 22
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG).

    Published in:
    British Journal of Haematology, 2009, v. 144, n. 1, p. 95, doi. 10.1111/j.1365-2141.2008.07394.x
    By:
    • Schweighofer, Carmen D.;
    • Ritgen, Matthias;
    • Eichhorst, Barbara F.;
    • Busch, Raymonde;
    • Abenhardt, Wolfgang;
    • Kneba, Michael;
    • Hallek, Michael;
    • Wendtner, Clemens-Martin
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches.

    Published in:
    British Journal of Haematology, 2009, v. 144, n. 1, p. 107, doi. 10.1111/j.1365-2141.2008.07429.x
    By:
    • Ryan, Jacqueline;
    • Quinn, Fiona;
    • Meunier, Armelle;
    • Boublikova, Ludmila;
    • Crampe, Mireille;
    • Tewari, Prerna;
    • O’Marcaigh, Aengus;
    • Stallings, Ray;
    • Neat, Michael;
    • O’Meara, Ann;
    • Breatnach, Fin;
    • McCann, Shaun;
    • Browne, Paul;
    • Smith, Owen;
    • Lawler, Mark
    Publication type:
    Article
    22